D. Nikcevich

发表

A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma

J. Sloan, N. Foster, M. Aubry, 2008, Cancer.

Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results

B. Scheithauer, J. Buckner, E. Galanis, 2008, Journal of Neuro-Oncology.

Natural killer cell-enriched donor lymphocyte infusions from A 3-6/6 HLA matched family member following nonmyeloablative allogeneic stem cell transplantation.

V. Hasselblad, K. Sullivan, Yiping Yang, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9).

C. Loprinzi, A. Dueck, A. Jatoi, 2010, Lung cancer.

The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9

P. Novotny, J. Sloan, C. Loprinzi, 2013, Supportive Care in Cancer.

Interleukin-1 genetic polymorphisms and their relationship to the cancer anorexia/weight loss syndrome in metastatic gastric and gastroesophageal junction adenocarcinoma.

N. Foster, S. Dakhil, A. Jatoi, 2007, The journal of supportive oncology.

Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group.

N. Foster, S. Dakhil, S. Alberts, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.

J. Sloan, C. Loprinzi, J. Kugler, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.

P. Novotny, J. Sloan, C. Loprinzi, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group.

N. Foster, K. Rowland, S. Alberts, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase 2 trial of pemetrexed disodium and carboplatin in previously untreated extensive‐stage small cell lung cancer, N0423

J. Jett, N. Foster, K. Rowland, 2010, Cancer.

A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia

T. Shanafelt, N. Kay, B. Laplant, 2016, Oncotarget.

Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC

E. Perez, J. Sloan, C. Loprinzi, 2009, Breast Cancer Research and Treatment.

A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group.

K. Rowland, S. Dakhil, P. Flynn, 2007, Urology.

The proteolysis-inducing factor: in search of its clinical relevance in patients with metastatic gastric/esophageal cancer.

N. Foster, M. Palcic, A. Jatoi, 2006, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Akt inhibitor MK‐2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study

Deborah A. Bowen, T. Habermann, T. Shanafelt, 2017, American journal of hematology.

Inhaled steroids as prophylaxis for delayed pulmonary toxicity syndrome in breast cancer patients undergoing high-dose chemotherapy and autologous stem cell transplantation.

G. Broadwater, D. Rizzieri, N. Chao, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A phase III randomized trial of two different dosing schedules of erythropoietin (EPO) in patients with cancer-associated anemia: North Central Cancer Treatment Group (NCCTG) Study N02C2

P. Novotny, J. Sloan, C. Loprinzi, 2005 .

Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM

J. Uhm, R. Arusell, J. Buckner, 2010, Journal of Neuro-Oncology.

Denileukin Diftitox in Combination with Rituximab for Previously Untreated Follicular B-cell Non-Hodgkin’s Lymphoma

S. Ansell, Hui Tang, C. Erlichman, 2011, Leukemia.

Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium.

J. Kugler, K. Rowland, V. Suman, 2006, Gynecologic oncology.

Effect of intravenous calcium and magnesium (IV CaMg) on oxaliplatin-induced sensory neurotoxicity (sNT) in adjuvant colon cancer: Results of the phase III placebo-controlled, double-blind NCCTG trial N04C7

P. Novotny, J. Sloan, C. Loprinzi, 2008 .

Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia: A phase II study from the North Central Cancer Treatment Group

N. Foster, J. Kugler, S. Alberts, 2005 .

Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance]).

Tsung-Teh Wu, D. Wigle, S. Alberts, 2021, European journal of cancer.

Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: protocol summary and interim report.

J. Winter, E. Jaffe, K. Takeshita, 2005, Clinical lymphoma.

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma.

T. Witzig, B. Laplant, D. Wender, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma.

T. Witzig, B. Laplant, D. Wender, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy‐associated anemia

P. Novotny, J. Sloan, D. Moore, 2015, American journal of hematology.

A Phase II NCCTG Study of Irinotecan and Docetaxel in Previously Treated Patients with Non-Small Cell Lung Cancer

J. Jett, S. Hillman, K. Rowland, 2006, Cancer investigation.

Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma.

D. Berry, J. Winter, C. Flowers, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term survivors of metastatic colorectal cancer treated with systemic chemotherapy alone: a north central cancer treatment group review of 3811 patients, n0144.

D. Sargent, R. Goldberg, M. O’connell, 2009, Clinical colorectal cancer.

Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer.

David P Steensma, P. Novotny, J. Sloan, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy of gabapentin in the management of chemotherapy‐induced peripheral neuropathy

G. Y. Wong, P. Novotny, G. Wong, 2007, Cancer.

A phase III double blinded, placebo controlled, randomized trial of gabapentin in patients with chemotherapy-induced peripheral neuropathy: A North Central Cancer Treatment Group study

G. Y. Wong, P. Novotny, G. Wong, 2005 .

Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer.

C. Obasaju, J. Jett, S. Mandrekar, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stimulation of hematopoiesis in untreated and cyclophosphamide treated mice by the inhibition of prostaglandin synthesis.

M. Young, D. Nikcevich, H. Wepsic, 1986, Journal of immunopharmacology.

Stimulation of suppressor cells in the bone marrow and spleens of high dose cyclophosphamide-treated C57Bl/6 mice.

G. E. Kaufman, M. Young, D. Nikcevich, 1987, Cellular immunology.

Phase II NCCTG Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer

J. Jett, S. Hillman, N. Foster, 2006, American journal of clinical oncology.

Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphoma.

J. Cerhan, P. Kurtin, T. Habermann, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

N0338 phase II trial of docetaxel and carboplatin administered every two weeks as induction therapy for stage II or III breast cancer

Vivek Roy, E. Perez, B. Pockaj, 2008 .

A phase II trial of nab‐paclitaxel (ABI‐007) and carboplatin in patients with unresectable stage IV melanoma

R. McWilliams, V. Suman, S. Markovic, 2011, Cancer.

Fulvestrant in women with advanced breast cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group Trial N0032.

E. Perez, J. Ingle, K. Rowland, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

253 T CELL MODULATION COMBINED WITH INTRATUMORAL INJECTIONS OF CPG OLIGODEOXYNUCLEOTIDES CURES LARGE AND SYSTEMIC LYMPHOMA TUMORS IN MICE

L. Gordon, P. Kurtin, M. Goldwasser, 2008 .

Final results of NCCTG N0489: Epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy (ER-CHOP) in patients with previously untreated diffuse large B-cell lymphoma.

D. Moore, T. Witzig, M. Maurer, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stimulation of prostaglandin-dependent macrophage suppressor cells by the subcutaneous injection of polyunsaturated fatty acids.

M. Young, D. Nikcevich, H. Wepsic, 1986, Cellular immunology.

Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma.

P. Kurtin, T. Habermann, M. Vignetti, 2011, Blood.

Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)

T. Whelan, G. Sledge, D. Cella, 2018, Breast Cancer Research and Treatment.

The value of looking. Multiple myeloma discovered by an unusual finding in Gram-stained spinal fluid.

D. Nikcevich, M. Patel, 2002, North Carolina medical journal.

Inhibition of Interleukin 2 (IL-2)-stimulated tyrosine kinase activity by leflunomide

A. Chong, James W. Williams, A. Finnegan, 1994, Agents and Actions.

North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane.

E. Perez, K. Rowland, A. Dueck, 2012, Clinical breast cancer.

Association of obesity with DNA mismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating in NCCTG and NSABP adjuvant chemotherapy trials.

D. Sargent, T. Smyrk, N. Foster, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tolerability of lapatinib given concurrently with paclitaxel and trastuzumab as part of adjuvant therapy in patients with resected HER2+ breast cancer: initial safety data from the Mayo Clinic cancer research consortium trial RC0639.

E. Perez, S. Franco, S. Dakhil, 2009 .

A Phase II Trial of Docetaxel and Carboplatin Administered Every 2 Weeks as Preoperative Therapy for Stage II or III Breast Cancer: NCCTG Study N0338

E. Perez, B. Pockaj, D. Northfelt, 2013, American journal of clinical oncology.

A phase II study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy (ER-CHOP) in patients with previously untreated diffuse large B-cell lymphoma

D. Moore, T. Witzig, M. Maurer, 2008 .

The Results of combined modality therapy for limited stage small cell lung cancer (LD-SCLC) in the elderly.

J. Jett, S. Mandrekar, A. Adjei, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MODIFICATION OF THE INDUCTION OF BCGcw SUPPRESSOR CELLS BY MITOMYCIN C1

Y. Mizushima, D. Nikcevich, H. T. Wepsic, 1985 .

Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma.

P. Kurtin, T. Habermann, T. Witzig, 2011, Blood.

Phase II study of rituximab and cladribine (2-CDA) in newly diagnosed mantle cell lymphoma (MCL) (N0189).

S. Dakhil, R. Morton, W. White, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma.

D. Berry, J. Winter, C. Flowers, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma.

P. Kurtin, T. Habermann, T. Witzig, 2011, Blood.